Eterna Therapeutics Inc (ERNA) — Capital Reinvestment Ratio
Eterna Therapeutics Inc (ERNA) has a Capital Reinvestment Ratio of 0.05x as of March 2019, meaning it reinvests 0% of its operating cash flow ($780.00K) in capital expenditures ($41.00K). See ERNA net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eterna Therapeutics Inc Capital Reinvestment Ratio (2009–2019)
This chart tracks Eterna Therapeutics Inc's Capital Reinvestment Ratio across 9 annual periods. Check how aggressively does Eterna Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eterna Therapeutics Inc (2009–2019)
Year-by-year Capital Reinvestment Ratio for Eterna Therapeutics Inc from 2009 to 2019. For live market cap and broader valuation context, see Eterna Therapeutics Inc (ERNA) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.40x | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $2.50 Million | $1.91 Million | — |